- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Endorectal MRI foretells prostate cancer prognosis
Researchers have found that endorectal MRI can accurately predict recurrence and development of metastatic disease in patients about to undergo radiation therapy for prostate cancer. Study findings suggest a stronger management role for MRI.
Researchers have found that endorectal MRI can accurately predict recurrence and development of metastatic disease in patients about to undergo radiation therapy for prostate cancer. Study findings suggest a stronger management role for MRI.
Dr. Fergus V. Coakley, a professor of radiology and urology at the University of California, San Francisco, and colleagues retrospectively analyzed images from 80 men with prostate cancer who had an MR scan before undergoing external-beam radiation therapy. The investigators recorded tumor findings, treatment, and outcomes and used regression analysis to correlate survival with specific characteristics of prostate disease. They found that MRI could accurately predict post-treatment recurrence and disease spread based on the presence and degree of extracapsular extension (Radiology 2008;247:141-146).
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
